4.6 Editorial Material

Conventional ovarian stimulation no longer exists: welcome to the age of individualized ovarian stimulation

Journal

REPRODUCTIVE BIOMEDICINE ONLINE
Volume 23, Issue 2, Pages 141-148

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.rbmo.2011.05.008

Keywords

anti-Mullerian hormone (AMH); chronological age; extremes of ovarian response; individualized ovarian stimulation; IVF

Ask authors/readers for more resources

The prediction of extremes of ovarian response to stimulation and the irreversibility of reduced ovarian reserve remain important clinical and basic science research issues of IVF treatment. Recommending commencement of ovarian stimulation using any of the available exogenous compounds without knowledge of individual ovarian potentials is simplistic and dangerous because of the possible adverse consequences for the woman. The identification of groups of patients likely to benefit from one protocol than another is central to the workup process of IVF. Determining the agents for ovarian stimulation as well as the combination of them, the daily dose and duration according to some background information should be seen as the way to enhance safety and cost-effectiveness. This discussion paper aims to introduce the concept of individualized ovarian stimulation in routine clinical practice and to generate interest for tailored stimulation protocols. (C) 2011, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available